Leadiant Biosciences, Inc. recalls
Every recall we track for Leadiant Biosciences, Inc. — 4 in all, from 2018–2023 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
4 recalls since 2017.
All FDA recall records for Leadiant Biosciences, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 2 | 0 | 2 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 1 | 0 | 1 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 1 | 1 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled Leadiant Biosciences, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Leadiant Biosciences, Inc. recalls
4 shown- UnratedDrug
Leadiant Biosciences, Inc. recalls Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc.,
Leadiant Biosciences recalls Abelcet (Amphotericin B Lipid Complex) injection due to potential contamination with Cupriavidus pauculus. This may cause infection in patients receiving the medication.
Leadiant BiosciencesFeb 3, 2023 - Lower riskDrug
Leadiant Biosciences, Inc. recalls Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured
Leadiant Biosciences recalls Cystaran 0.44% ophthalmic solution due to decreased active ingredient. Patients should contact their doctor for alternative treatment options.
Leadiant BiosciencesSep 24, 2020 - Lower riskDrug
LEADIANT BIOSCIENCES, INC recalls Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc.
Leadiant Biosciences recalls Cystaran 0.44% ophthalmic solution due to subpotent cysteamine hydrochloride. Affected lots expire June 2018 or July 2018. Do not use if you have this product.
Leadiant BiosciencesApr 9, 2018 - Lower riskDrug
LEADIANT BIOSCIENCES, INC recalls Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc.,
Leadiant Biosciences recalls Cystaran 0.44% ophthalmic solution due to subpotent cysteamine hydrochloride. Affected units have specific NDC and lot numbers. Contact for remedy details.
Leadi:ant BiosciencesFeb 14, 2018
Leadiant Biosciences, Inc. recall questions
How many recalls has Leadiant Biosciences, Inc. had?
4 recalls from Leadiant Biosciences, Inc. are on record with U.S. safety agencies, from 2018–2023.
What is the most recent Leadiant Biosciences, Inc. recall?
Leadiant Biosciences, Inc. recalls Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc.,, dated Feb 3, 2023. Every Leadiant Biosciences, Inc. recall is listed on this page, newest first.
What should I do if I have a recalled Leadiant Biosciences, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Leadiant Biosciences, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.